| Pharmaceutical Information |
| Drug Name |
Malathion |
| Drug ID |
BADD_D01346 |
| Description |
Malathion is a parasympathomimetic organophosphate compound that is used as an insecticide for the treatment of head lice. Malathion is an irreversible cholinesterase inhibitor and has low human toxicity. |
| Indications and Usage |
For patients infected with Pediculus humanus capitis (head lice and their ova) of the scalp hair. |
| Marketing Status |
Prescription; Discontinued |
| ATC Code |
P03AX03 |
| DrugBank ID |
DB00772
|
| KEGG ID |
D00534
|
| MeSH ID |
D008294
|
| PubChem ID |
4004
|
| TTD Drug ID |
D0K3LW
|
| NDC Product Code |
51672-5293; 68022-0001; 51672-5294 |
| Synonyms |
Malathion | Karbofos | Carbophos | Carbafos | Carbofos | Prioderm | Sadophos | Cythion |
|
| Chemical Information |
| Molecular Formula |
C10H19O6PS2 |
| CAS Registry Number |
121-75-5 |
| SMILES |
CCOC(=O)CC(C(=O)OCC)SP(=S)(OC)OC |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
